Gani Zahid, Kumar Ajay, Raje Manoj, Raje Chaaya Iyengar
Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Phase X, Sector 67, SAS Nagar, Punjab 160067, India; Center of Microbial Pathogenesis, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA.
Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Phase X, Sector 67, SAS Nagar, Punjab 160067, India; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Drug Discov Today. 2025 Feb;30(2):104305. doi: 10.1016/j.drudis.2025.104305. Epub 2025 Feb 1.
Antimicrobial peptides (AMPs) are a diverse group of naturally occurring molecules produced by eukaryotes and prokaryotes. They have an important role in innate immunity via their direct microbicidal properties or immunomodulatory activities against pathogens. With the widespread occurrence of antimicrobial resistance (AMR), AMPs are considered as viable alternatives for the treatment of multidrug-resistant microbes, inflammation, and, wound healing. The broad-spectrum antibacterial activity of AMPs is predominantly attributed to membrane disruption, leading to the formation of transmembrane pores and, eventually, cell lysis. However, mechanisms related to inhibition of cell wall synthesis, nucleic acid synthesis, protein synthesis, or enzymatic activity are also associated with these peptides. In this review, we discuss our current understanding, therapeutic uses and challenges associated with the clinical applications of AMPs.
抗菌肽(AMPs)是真核生物和原核生物产生的一类多样的天然分子。它们通过直接的杀菌特性或针对病原体的免疫调节活性在先天免疫中发挥重要作用。随着抗菌药物耐药性(AMR)的广泛出现,抗菌肽被认为是治疗多重耐药微生物、炎症和伤口愈合的可行替代方案。抗菌肽的广谱抗菌活性主要归因于膜破坏,导致跨膜孔的形成,最终导致细胞裂解。然而,与抑制细胞壁合成、核酸合成、蛋白质合成或酶活性相关的机制也与这些肽有关。在这篇综述中,我们讨论了我们目前对抗菌肽临床应用的理解、治疗用途和挑战。